FDA Inspection 1199968 — Palisades Compounding Pharmacy

Palisades Compounding Pharmacy — FEI 3008174851

The FDA completed an inspection of Palisades Compounding Pharmacy on March 15, 2023 in Pacific Palisades, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 15, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pacific Palisades, CA (United States)

Citations

IDCFRDescription
18938FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination